OncoCyte Corp Announces Equity Placement and Fundraising Efforts
Company Announcements

OncoCyte Corp Announces Equity Placement and Fundraising Efforts

OncoCyte Corp (OCX) just unveiled an announcement.

Oncocyte Corporation has initiated a private placement transaction issuing over 5 million common shares and pre-funded warrants to accredited investors, targeting a closing date around April 15, 2024, with expected proceeds of approximately $15.8 million before expenses. These funds are earmarked for general corporate purposes and to redeem outstanding Series A Preferred Stock. The deal includes a registration rights agreement to facilitate the resale of the shares and warrants, and Needham & Company, LLC is serving as the placement agent for this transaction.

See more insights into OCX stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskOncoCyte Announces Andrea James as New CFO and Principal Officer
GlobeNewswireOncocyte Appoints Andrea James as Chief Financial Officer
TheFlyOncoCyte appoints Andrea James to CFO
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!